Altos Venture
4
9M
2
0.33
1
0.50
- Areas of investment
Summary
Altos Venture appeared to be the VC, which was created in 2011. The main office of represented VC is situated in the Allschwil. The fund was located in Europe if to be more exact in Switzerland.
Among the various public portfolio startups of the fund, we may underline ProteoMediX We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Altos Venture, startups are often financed by Zu00fcrcher Kantonal Bank, BioValley Business Angels Club (BioBAC), Altos Ventures. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, several private, Walter Fischl. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, several private, Walter Fischl.
Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2014. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Rounds per year
- 0.33
- Follow on index
- 0.50
- Investments by industry
- Health Care (3)
- Biotechnology (3)
- Medical (3)
- Marketplace (1)
- E-Commerce (1) Show 1 more
- Investments by region
-
- South Korea (1)
- Switzerland (3)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 112M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ProteoMediX | 09 Apr 2014 | Biotechnology, Health Care, Medical | Early Stage Venture | 3M | Switzerland, Zurich |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.